An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Campa, D, Kaaks, R, Le Marchand, L, Haiman, C, Travis, R, Ziegler, R, Hunter, D, Lindstroem, S, Canzian, F
التنسيق:	Conference item
منشور في:	2012

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
حسب: Tsilidis, K, وآخرون
منشور في: (2013)

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
حسب: Lindström, S, وآخرون
منشور في: (2012)

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
حسب: Ahn, J, وآخرون
منشور في: (2009)

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
حسب: Setiawan, V, وآخرون
منشور في: (2007)

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
حسب: Cox, D, وآخرون
منشور في: (2006)

Genetic polymorphisms of the <it>GNRH1 </it>and <it>GNRHR </it>genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
حسب: Lund Eiliv, وآخرون
منشور في: (2009-07-01)

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
حسب: Patel, A, وآخرون
منشور في: (2008)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium
حسب: Campa, D, وآخرون
منشور في: (2011)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
حسب: Campa, D, وآخرون
منشور في: (2011)

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
حسب: Mondul, A, وآخرون
منشور في: (2013)

Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
حسب: Barrdahl, M, وآخرون
منشور في: (2014)

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
حسب: Joshi, A, وآخرون
منشور في: (2014)

Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
حسب: Machiela, M, وآخرون
منشور في: (2012)

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
حسب: Chen, Y, وآخرون
منشور في: (2007)

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
حسب: Lindstrom, S, وآخرون
منشور في: (2011)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
حسب: Shui, I, وآخرون
منشور في: (2014)

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
حسب: Lindström, S, وآخرون
منشور في: (2010)

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
حسب: Travis, R, وآخرون
منشور في: (2009)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
حسب: Shui, I, وآخرون
منشور في: (2014)

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
حسب: Sara Lindstrom, وآخرون
منشور في: (2011-02-01)

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
حسب: Mathew, Angelin Tresa, وآخرون
منشور في: (2022)

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
حسب: Mathew, Angelin T., وآخرون
منشور في: (2022)

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
حسب: Agarwal, D, وآخرون
منشور في: (2014)

Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
حسب: Tsilidis, K, وآخرون
منشور في: (2012)

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.
حسب: Milne, R, وآخرون
منشور في: (2014)

Characteristics of Breast Cancer at First Presentation in Sudanese Patients Attending the National Cancer Institute–University of Gezira (NCI–UG)
حسب: Muna Ahmed Eltayeb, وآخرون
منشور في: (2020-08-01)

Haplotypes of the estrogen receptor beta gene and breast cancer risk.
حسب: Cox, D, وآخرون
منشور في: (2008)

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
حسب: Koutros, S, وآخرون
منشور في: (2010)

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
حسب: Yang, X, وآخرون
منشور في: (2011)

Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198
حسب: Anna D. Cirac, وآخرون
منشور في: (2017-06-01)

Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.
حسب: Jirong Long, وآخرون
منشور في: (2010-06-01)

A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
حسب: Schumacher, F, وآخرون
منشور في: (2007)

The role of osteoprotegerin in breast and prostate cancer
حسب: Holen, I, وآخرون
منشور في: (2002)

The impact of transcription on metabolism in prostate and breast cancers
حسب: Poulose, N, وآخرون
منشور في: (2018)

Frequency of breast cancer subtypes among African American women in the AMBER consortium
حسب: Emma H. Allott, وآخرون
منشور في: (2018-02-01)

Nutrition and breast cancer.
حسب: Key, T, وآخرون
منشور في: (2003)

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
حسب: Foluso O. Ademuyiwa, وآخرون
منشور في: (2022-12-01)

The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium
حسب: Tomotaka Ugai, وآخرون
منشور في: (2019-06-01)

Oestrogen exposure and breast cancer risk.
حسب: Travis, R, وآخرون
منشور في: (2003)

An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

مواد مشابهة

مواد مشابهة